Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1138090 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR29900600_1.fastq.gz | Fastqsanger.gz | |||
| SRR29900600_2.fastq.gz | Fastqsanger.gz | |||
| SRR29900601_1.fastq.gz | Fastqsanger.gz | |||
| SRR29900601_2.fastq.gz | Fastqsanger.gz | |||
| SRR29900602_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 68 |
Similar Datasets
Project description:Disease-specific protein corona adsorbed on nanocarriers critically determines their in vivo delivery efficiency. Given that macrophages can orchestrate inflammation resolution and mucosa repair, they are regarded as promising therapeutic targets in colitis. Here, we reveal that by altering the physicochemical properties of nanocarriers, we can manipulate the amount and composition of colitis-specific intestinal protein corona (C-IPC) specifically formed on orally administered nanoparticles (NPs), thereby improving colon macrophage targeting and colitis therapy. We demonstrate that increasing surface hydrophobicity of NPs boosts overall protein adsorption during C-IPC formation, leading to improved colon macrophage delivery and colitis therapeutic efficacy of high hydrophobic NPs (Phobic) loaded with budesonide. Moreover, further increasing the rigidity of Phobic can selectively enrich the corona with key macrophage-targeting related proteins, notably S100A8. This dual-optimized hydrophobicity-rigidity co-modulation approach generates an optimal C-IPC characterized by both high protein amount and a high proportion of targeting proteins. Benefiting from it, Phobic with high rigidity (Hard) further promoted the macrophage targeted drug delivery, thus more effectively attenuating the inflammation and restoring the immune homeostasis in male colitis rats. Our work develops a rational strategy of manipulating the disease-specific protein corona formation through multiple-physicochemical properties co-modulation for efficient drug delivery, holding broad promise for diverse nanocarriers and pathologies.
2026-01-21 | PXD071116 | Pride
Project description:Disease-specific protein corona adsorbed on nanocarriers critically determines their in vivo delivery efficiency. Given that macrophages can orchestrate inflammation resolution and mucosa repair, they are regarded as promising therapeutic targets in colitis. Here, we reveal that by altering the physicochemical properties of nanocarriers, we can manipulate the amount and composition of colitis-specific intestinal protein corona (C-IPC) specifically formed on orally administered nanoparticles (NPs), thereby improving colon macrophage targeting and colitis therapy. We demonstrate that increasing surface hydrophobicity of NPs boosts overall protein adsorption during C-IPC formation, leading to improved colon macrophage delivery and colitis therapeutic efficacy of high hydrophobic NPs (Phobic) loaded with budesonide. Moreover, further increasing the rigidity of Phobic can selectively enrich the corona with key macrophage-targeting related proteins, notably S100A8. This dual-optimized hydrophobicity-rigidity co-modulation approach generates an optimal C-IPC characterized by both high protein amount and a high proportion of targeting proteins. Benefiting from it, Phobic with high rigidity (Hard) further promoted the macrophage targeted drug delivery, thus more effectively attenuating the inflammation and restoring the immune homeostasis in male colitis rats. Our work develops a rational strategy of manipulating the disease-specific protein corona formation through multiple-physicochemical properties co-modulation for efficient drug delivery, holding broad promise for diverse nanocarriers and pathologies.
2026-01-21 | PXD071199 | Pride
Project description:LNPs have been demonstrated to hold great promise for the clinical advancement of RNA therapeutics. Continued exploration of LNPs for application in new disease areas requires identification and optimisation of leads in a high throughput way. Currently available high throughput in vivo screening platforms are well suited to screen for cellular uptake but less so for functional cargo delivery. We report on a platform which measures functional delivery of LNPs using unique peptide ‘barcodes’. We describe the design and selection of the peptide barcodes and the evaluation of these for the screening of LNPs. We show that proteomic analysis of peptide barcodes correlates with quantification and efficacy of barcoded reporter proteins both in vitro and in vivo and, that the ranking of selected LNPs using peptide barcodes in a pool correlates with ranking using alternative methods in groups of animals treated with individual LNPs. We show that this system is sensitive, selective, and capable of reducing the size of an in vivo study by screening up to 10 unique formulations in a single pool, thus accelerating the discovery of new technologies for mRNA delivery.
2024-10-17 | PXD053797 | Pride
Project description:Detecting strain-specific barcodes with mass spectrometry can facilitate the screening of genetically engineered bacterial libraries. Here, we introduce intact protein barcoding, a method to measure protein-based library barcodes and metabolites using flow-injection mass spectrometry (FI-MS). Protein barcodes are based on ubiquitin with N-terminal tags of six amino acids. We demonstrate that FI-MS detects intact ubiquitin proteins and identifies the mass of N-terminal barcodes. In the same analysis, we measured relative concentrations of primary metabolites. We constructed 6 ubiquitin-barcoded CRISPRi strains targeting metabolic enzymes, and analyzed their metabolic profiles and ubiquitin barcodes. FI-MS detected barcodes and distinct metabolome changes in CRISPRi-targeted pathways. We demonstrate the scalability of intact protein barcoding by measuring 132 ubiquitin barcodes in microtiter plates. These results show that intact protein barcoding enables fast and simultaneous detection of library barcodes and intracellular metabolites, opening up new possibilities for mass spectrometry-based barcoding.
2024-10-30 | MSV000096254 | MassIVE
Project description:Exosomes are nanosized extracellular vesicles which have been recently demonstrated as promising agents for tissue repair/regeneration by inducing and guiding appropriate immune responses in dystrophic pathologies. Unfortunately, the accurate manipulation of exosomes by controlling their biodistribution still poses significant challenges. Here we overcome this limitation by developing an externally controlled delivery system for primed ANXA1 myo-exosomes (Exomyo). Effective nanocarriers are realized by immobilizing the Exomyo onto ferromagnetic nanotubes (NT-MAG) to achieve a controlled delivery and localization of Exomyo into skeletal muscles by an applied external magnetic field. Quantitative muscle-level analyses revealed that macrophages dominate the uptake of Exomyo from NT-MAG in vivo, to synergistically promote beneficial muscle responses in a murine animal model of Duchenne Muscular Dystrophy (DMD) thanks to the successful localization of therapeutic Exomyo upon systemic injection. These findings provide valuable insights into the development of exosome-based therapies for muscle diseases and in general highlight the formulation of effective functional nanocarriers aimed at optimizing exosome biodistribution.
2024-07-23 | GSE263456 | GEO
Project description:Exosomes are nanosized extracellular vesicles which have been recently demonstrated as promising agents for tissue repair/regeneration by inducing and guiding appropriate immune responses in dystrophic pathologies. Unfortunately, the accurate manipulation of exosomes by controlling their biodistribution still poses significant challenges. Here we overcome this limitation by developing an externally controlled delivery system for primed ANXA1 myo-exosomes (Exomyo). Effective nanocarriers are realized by immobilizing the Exomyo onto ferromagnetic nanotubes (NT-MAG) to achieve a controlled delivery and localization of Exomyo into skeletal muscles by an applied external magnetic field. Quantitative muscle-level analyses revealed that macrophages dominate the uptake of Exomyo from NT-MAG in vivo, to synergistically promote beneficial muscle responses in a murine animal model of Duchenne Muscular Dystrophy (DMD) thanks to the successful localization of therapeutic Exomyo upon systemic injection. These findings provide valuable insights into the development of exosome-based therapies for muscle diseases and in general highlight the formulation of effective functional nanocarriers aimed at optimizing exosome biodistribution.
2024-07-23 | GSE263142 | GEO
Project description:Efficient and accurate nanocarrier development for targeted drug delivery is hindered by the inability to analyze cell-level biodistribution across intact whole organisms. We introduce SCP-Nano (Single Cell Precision Nanocarrier Identification), a deep learning pipeline designed to quantify the targeting of millions of cells by nanocarriers in whole-mouse bodies imaged at cellular resolution. SCP-Nano revealed the tissue distribution patterns of lipid nanoparticles (LNPs) following different injection routes at doses as low as 0.0005 mg/kg—far below the detection limits of conventional whole-body imaging techniques. Notably, we demonstrated that LNPs carrying SARS-CoV-2 spike mRNA reach heart tissue, leading to changes in the heart's protein composition that suggest immune activation and possible blood vessel damage. Additionally, we showed that SCP-Nano can analyze various types of nanocarriers, including liposomes, polyplexes, DNA origami, and adeno-associated viruses (AAVs). SCP-Nano's high sensitivity enables accurate 3D mapping of nanocarrier distribution throughout mouse bodies, even detecting very low levels in unexpected tissues. SCP-Nano is poised to accelerate the development of precise and safe nanocarrier-based therapeutics.
2024-12-06 | PXD056871 | Pride